A herbal tablet marketed as “P One Miracle Tab” sold across Nigerian online marketplaces and presented by distributors as a Ghanaian-made product carries no traceable Food and Drugs Authority (FDA) Ghana registration number, despite being marketed as a treatment for conditions including arthritis, stroke, hypertension, ulcers and menstrual pain. It is a case study in a wider regulatory blind spot: herbal products moving across West African borders faster than the region’s regulators can track them.

What the law requires
Under Ghana’s Food and Drugs Law, any product marketed for human treatment food, drug, herbal medicine, cosmetic or supplement must be registered with FDA Ghana before it can be legally sold. Registration requires disclosure of active ingredients, manufacturer details, batch numbering and, for herbal products in particular, evidence supporting any health claims made on the label. A search of the FDA Ghana public product registry, which lists more than 17,000 registered products, returned no entry for “P One” or “P One Miracle.”

What the label shows
A bottle of P.One Miracle Tab examined for this report is labeled as containing Moringa, packaged as 40 tablets 20 green, 20 white with a recommended dose of two of each, morning and evening. The label carries a manufacture date of July 2025, an expiry date of December 2028, a batch number (DG 3002), a contact line, and a code presented as a “REG NO”: TMP C83743.

That registration code does not follow the standard FDA Ghana product registration format. TMP more commonly refers to the Traditional Medicine Practice Council (TMPC), the statutory body established under Act 575 of 2000 to license herbal practitioners and their premises a distinct function from FDA Ghana’s product registration, which is what a tablet marketed to treat stroke and hypertension would require. Whether the code corresponds to a genuine TMPC licence, a misapplied FDA number, or neither, is something only the two regulators can clarify on record.

The label lists a Ghana manufacturer address of Accra North, Kolenton, opposite St. Theresa’s School.

The dating on the label is also worth scrutiny. A shelf life running from July 2025 to December 2028 roughly three and a half years is unusually long for a herbal product. Ghana’s own herbal medicine researchers have noted that because most herbal formulations lack the stability data to support extended shelf-life claims, FDA Ghana typically licenses herbal products for renewal at much shorter intervals, often annually.

A brand with its own counterfeiting problem
Complicating the picture further, the product’s own public Facebook page carries a notice warning customers that a “new p.one miracle tab” circulating in the market is not authorized, insisting the original packaging has not changed and urging buyers to look for what it calls the sole authentic version. In other words, even by the account of what presents itself as the brand’s official page, counterfeit versions of an already unregistered-looking product are in circulation which makes it harder for any regulator, or any consumer, to know precisely what they are buying, let alone trace it back to a single accountable manufacturer.

How it reaches Nigeria
Marketing material for the product lists a Nigerian distribution point at 165 Abeokuta Expressway, opposite GIG Motors, Iyanaipaja, Lagos evidence of an established cross-border supply chain moving the product from Ghana into Nigerian retail and online markets, marketed there with sweeping “total cure” health claims that neither FDA Ghana nor NAFDAC appears to have verified.

The wider problem
P One Miracle Tab is not an isolated case. NAFDAC has repeatedly warned that unregistered herbal products marketed as miracle cures are among the hardest to intercept precisely because they move through informal cross-border networks rather than licensed pharmaceutical wholesalers, often carrying borrowed, fabricated, or simply irrelevant certification codes designed to reassure buyers rather than satisfy regulators. A product manufactured without a valid FDA Ghana registration, sold across an international border, and now facing its own counterfeiting problem on top of that, illustrates exactly the kind of regulatory gap that allows unverified health claims to reach consumers in both countries unchecked until harm is reported after the fact rather than prevented beforehand.

This article has sought comment from FDA Ghana on the registration status of P One Miracle Tab and will update this report with any response received.

Mustapha Bature Sallama.
Medical/ Science Communicator,
Private Investigator, Criminal investigation and Intelligence Analysis.
International Conflict Management and Peace Building.USIP
[email protected]
+233-555-275-880

References
FDA Ghana Public Product Registry https://verifypermit.fdaghana.gov.gh/publicsearch

FDA Ghana, “Product Registration” https://fdaghana.gov.gh/services-2/product-registration/

Traditional Medicine Practice Council, Act 575 (2000)